Eli Lilly and Company announced that Melissa Seymour will join the company as executive vice president of Global Quality and member of the company's Executive Committee, effective July 22, 2024. Seymour currently serves as the chief quality officer for Bristol Myers Squibb and succeeds Johna Norton, whose retirement after 34 years of service was announced earlier this year. Seymour is recognized as one of the foremost quality leaders in the pharmaceutical industry.

She has held senior leadership roles at global pharmaceutical companies, including Bristol Myers Squibb and Biogen, with extended experience at Novo Nordisk and Glaxo Smith Kline. She has led the development of quality compliance strategies, implemented quality processes and systems, and developed talent to ensure the highest level of quality and compliance in the pharmaceutical industry. Seymour holds bachelor's degrees in biological sciences and biochemistry from North Carolina State University and an executive MBA from Duke University.

She also has several quality-related certifications from the American Society for Quality, and contributes to the larger industry through participation on nonprofit boards, including the Parenteral Drug Association and other consortiums.